However, other studies have also confirmed that CEACAM1 expression is significantly decreased in cancers such as hepatocellular carcinoma19, bladder cancer20, 21, kidney cancer22, etc., thereby indicating that CEACAM1 may function as a potential tumour suppressor. This evidence concerns the gene CEACAM1 and neoplasm.